Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MabThera in RA patients with inadequate response to TNF inhibition
NCT00424502Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Primary completion
- Oct 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Jan 2007; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00424502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424502.